IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

May 2022 (Vol: 2022, Issue: 5)

Next Issue >>

Download pdf of entire issue

Section: Licensing
Jazz Licenses Sumitomo’s Narcolepsy Drug for US$50 M Upfront Published: 7 May-2022
By: Lucy Haggerty
Abstract Fulltext:
Bristol Myers Squibb Licenses BridgeBio’s BBP-398 for Cancer Published: 31 May-2022
By: Lucy Haggerty
Abstract Fulltext:
Section: Mergers & Acquisitions
Pfizer Buys Biohaven for US$11.6 B Published: 13 May-2022
By: Lucy Haggerty
Abstract Fulltext:
Section: Research & Development
Amphista Enters Protein Degradation Collaborations with Bristol-Myers Squibb and Merck Published: 26 May-2022
By: Lucy Haggerty
Abstract Fulltext:

Login Problems

Please enter your username or email address and we will email you your login details.